1 1392 103 IMPACT OF YOGA AND MEDITATION ON CELLULAR AGING IN APPARENTLY HEALTHY INDIVIDUALS: A PROSPECTIVE, OPEN-LABEL SINGLE-ARM EXPLORATORY STUDY. THIS STUDY WAS DESIGNED TO EXPLORE THE IMPACT OF YOGA AND MEDITATION BASED LIFESTYLE INTERVENTION (YMLI) ON CELLULAR AGING IN APPARENTLY HEALTHY INDIVIDUALS. DURING THIS 12-WEEK PROSPECTIVE, OPEN-LABEL, SINGLE ARM EXPLORATORY STUDY, 96 APPARENTLY HEALTHY INDIVIDUALS WERE ENROLLED TO RECEIVE YMLI. THE PRIMARY ENDPOINTS WERE ASSESSMENT OF THE CHANGE IN LEVELS OF CARDINAL BIOMARKERS OF CELLULAR AGING IN BLOOD FROM BASELINE TO WEEK 12, WHICH INCLUDED DNA DAMAGE MARKER 8-HYDROXY-2'-DEOXYGUANOSINE (8-OH2DG), OXIDATIVE STRESS MARKERS REACTIVE OXYGEN SPECIES (ROS), AND TOTAL ANTIOXIDANT CAPACITY (TAC), AND TELOMERE ATTRITION MARKERS TELOMERE LENGTH AND TELOMERASE ACTIVITY. THE SECONDARY ENDPOINTS WERE ASSESSMENT OF METABOTROPHIC BLOOD BIOMARKERS ASSOCIATED WITH CELLULAR AGING, WHICH INCLUDED CORTISOL, BETA-ENDORPHIN, IL-6, BDNF, AND SIRTUIN-1. AFTER 12 WEEKS OF YMLI, THERE WERE SIGNIFICANT IMPROVEMENTS IN BOTH THE CARDINAL BIOMARKERS OF CELLULAR AGING AND THE METABOTROPHIC BIOMARKERS INFLUENCING CELLULAR AGING COMPARED TO BASELINE VALUES. THE MEAN LEVELS OF 8-OH2DG, ROS, CORTISOL, AND IL-6 WERE SIGNIFICANTLY LOWER AND MEAN LEVELS OF TAC, TELOMERASE ACTIVITY, BETA-ENDORPHIN, BDNF, AND SIRTUIN-1 WERE SIGNIFICANTLY INCREASED (ALL VALUES P < 0.05) POST-YMLI. THE MEAN LEVEL OF TELOMERE LENGTH WAS INCREASED BUT THE FINDING WAS NOT SIGNIFICANT (P = 0.069). YMLI SIGNIFICANTLY REDUCED THE RATE OF CELLULAR AGING IN APPARENTLY HEALTHY POPULATION.	2017	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
2   35  44 A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION MIGHT POSITIVELY MODIFY CELLULAR AGING IN INDIAN OBESE INDIVIDUALS: A RANDOMIZED-CONTROLLED TRIAL. BACKGROUND: TELOMERES AND TELOMERASE ARE CONSIDERED CARDINAL BIOMARKERS OF CELLULAR AGING. SHORTER TELOMERES AND LOW TELOMERASE ACTIVITY HAVE BEEN ASSOCIATED WITH OBESITY AND ACCELERATED AGING. OBJECTIVE: TO COMPARE THE EFFECTS OF A YOGA-BASED LIFESTYLE INTERVENTION (YBLI) WITH THE STANDARD OF CARE (SOC) ON CELLULAR AGING BY ESTIMATING TELOMERE LENGTH (TL) AND TELOMERASE ACTIVITY IN OBESITY. DESIGN AND SETTING: A PARALLEL, TWO-ARM, RANDOMIZED-CONTROLLED TRIAL WAS CONDUCTED AT THE INTEGRAL HEALTH CLINIC, DEPARTMENT OF PHYSIOLOGY, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, FROM MARCH 2017 TO OCTOBER 2019. PARTICIPANTS: OBESE (N = 72), BODY MASS INDEX (BMI), 25-35 KG/M(2), AGED 20-45 YEARS, MALE (21), AND FEMALE (51). INTERVENTION: SEVENTY-TWO OBESE PARTICIPANTS WERE RANDOMIZED TO RECEIVE EITHER A 12-WEEK SOC (N = 36) OR YBLI (N = 36). SOC INCLUDED MANAGEMENT OF OBESITY AS PER INDIAN GUIDELINES INCLUDING A HYPOCALORIC INDIVIDUALIZED DIET AND PHYSICAL ACTIVITY. THE PRETESTED YBLI INCLUDED ASANA (PHYSICAL POSTURES), PRANAYAMA (BREATHING EXERCISES), AND MEDITATION. METHODS: BLOOD SAMPLES WERE COLLECTED FROM BOTH THE GROUPS AT BASELINE, 2, 4, AND 12 WEEKS. DNA WAS EXTRACTED FROM PERIPHERAL BLOOD MONONUCLEAR CELLS. TL WAS MEASURED BY QUANTITATIVE PCR, AND SERUM TELOMERASE LEVELS BY IMMUNOASSAY. OUTCOME MEASURES: PRIMARY OUTCOME MEASURES WERE THE CHANGES IN THE TL AND TELOMERASE LEVELS BETWEEN THE TWO GROUPS AT WEEK 12. SECONDARY OUTCOME MEASURES WERE THE CHANGES IN TL AND TELOMERASE, AND ANTHROPOMETRIC PARAMETERS (BODY WEIGHT, BMI, WAIST-TO-HIP RATIO) AT 2, 4, AND 12 WEEKS OF INTERVENTION IN BOTH SOC AND YBLI GROUPS. RESULTS: THERE WERE NO SIGNIFICANT CHANGES IN TL AND TELOMERASE LEVELS BETWEEN THE GROUPS AT WEEK 12. THE TL WAS SIGNIFICANTLY GREATER IN THE YBLI GROUP VERSUS THE SOC GROUP (P < 0.0001) AT 2 WEEKS. THE ANTHROPOMETRIC AND PHYSIOLOGICAL PARAMETERS WERE INFLUENCED POSITIVELY BY BOTH SOC AND YBLI. CONCLUSION: THE STUDY DID NOT MEET THE PRIMARY OBJECTIVE, ALTHOUGH THE RESULTS ARE SUGGESTIVE OF A POSITIVE IMPACT OF YBLI ON AGING IN OBESITY AS NOTED WITHIN THE YBLI GROUP. HOWEVER, THE RESULTS SHOULD BE INTERPRETED CAREFULLY, AND IN THE LIGHT OF OTHER PUBLISHED DATA. LARGER STUDIES TO BETTER UNDERSTAND THE POSSIBLE POSITIVE BENEFITS OF YBLI ON CELLULAR AGING ARE RECOMMENDED. CLINICAL TRAIL REGISTRATION NO. CTRI/2016/08/007136.	2022	

3 2038  42 TELOMERASE ACTIVITY AND CELLULAR AGING MIGHT BE POSITIVELY MODIFIED BY A YOGA-BASED LIFESTYLE INTERVENTION. OBJECTIVES: RECENT STUDIES SHOWED THAT A BRIEF YOGA-BASED LIFESTYLE INTERVENTION WAS EFFICACIOUS IN REDUCING LEVELS OF OXIDATIVE STRESS AND CELLULAR AGING IN OBESE MEN. THE OBJECTIVE OF THIS CASE REPORT WAS TO ASSESS THE EFFICACY OF THIS INTERVENTION IN REDUCING THE LEVELS OF BIOCHEMICAL MARKERS OF CELLULAR AGEING, OXIDATIVE STRESS, AND INFLAMMATION AT BASELINE (DAY 0), AT THE END OF ACTIVE INTERVENTION (DAY 10), AND FOLLOW-UP AT DAY 90. DESIGN: SINGLE CASE REPORT FROM A PROSPECTIVE ONGOING STUDY WITH PRE-POST DESIGN ASSESSING THE LEVEL OF VARIOUS MARKERS OF CELLULAR AGING. SETTING: INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY CONDUCTING MEDITATION AND YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR MANAGEMENT OF CHRONIC DISEASES. PATIENT: A 31-YEAR-OLD MAN WITH CLASS I OBESITY (BODY-MASS INDEX, 29.5 KG/M(2)) WHO PRESENTED TO THE MEDICINE OUTPATIENT DEPARTMENT AT ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI, INDIA, WITH A HISTORY OF FATIGUE, DIFFICULTY LOSING WEIGHT, AND LACK OF MOTIVATION. HE NOTED A MARKED DECREASE IN HIS ENERGY LEVEL, PARTICULARLY IN THE AFTERNOON. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDED ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), STRESS MANAGEMENT, GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. RESULTS: FROM BASELINE (DAY 0) TO DAY 90, THE ACTIVITY OF TELOMERASE AND LEVELS OF BETA-ENDORPHINS, PLASMA CORTISOL, AND INTERLEUKIN-6 INCREASED, AND A SUSTAINED REDUCTION IN OXIDATIVE STRESS MARKERS, SUCH AS REACTIVE OXYGEN SPECIES AND 8-HYDROXY-2-DEOXY-GUANOSINE LEVELS. CONCLUSIONS: ADOPTING YOGA/MEDITATION-BASED LIFESTYLE MODIFICATION CAUSES REVERSAL OF MARKERS OF AGING, MAINLY OXIDATIVE STRESS, TELOMERASE ACTIVITY, AND OXIDATIVE DNA DAMAGE. THIS MAY NOT ONLY DELAY AGING AND PROLONG A YOUTHFUL HEALTHY LIFE BUT ALSO DELAY OR PREVENT ONSET OF SEVERAL LIFESTYLE-RELATED DISEASES, OF WHICH OXIDATIVE STRESS AND INFLAMMATION ARE THE CHIEF CAUSE. THIS REPORT SUGGESTS THIS SIMPLE LIFESTYLE INTERVENTION MAY BE THERAPEUTIC FOR OXIDATIVE DNA DAMAGE AND OXIDATIVE STRESS.	2015	
                                                                                                                                                                                                                                                                                                                                                                            
4 2854  43 YOGA- AND MEDITATION-BASED LIFESTYLE INTERVENTION INCREASES NEUROPLASTICITY AND REDUCES SEVERITY OF MAJOR DEPRESSIVE DISORDER: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: CURRENT INTERVENTIONS FOR MAJOR DEPRESSIVE DISORDER (MDD) ARE SUBOPTIMAL, AND ONLY ONE THIRD RESPOND TO THEM ON INITIAL TREATMENT. NEUROPLASTICITY THEORIES ARE THE BASIS FOR SEVERAL EMERGING TREATMENTS. EVIDENCE ON THE IMPACT OF YOGA, A WELL-KNOWN MIND-BODY INTERVENTION, ON NEUROPLASTICITY IN MDD IS LIMITED. OBJECTIVES: TO DETERMINE THE EFFECTS OF 12-WEEK YOGA- AND MEDITATION-BASED LIFESTYLE INTERVENTION (YMLI) ON DEPRESSION SEVERITY AND SYSTEMIC BIOMARKERS OF NEUROPLASTICITY IN ADULT MDD PATIENTS ON ROUTINE DRUG TREATMENT. METHODS: A TOTAL OF 58 MDD PATIENTS WERE RANDOMIZED INTO YOGA OR CONTROL GROUP. THE SEVERITY OF DEPRESSION WAS ASSESSED WITH BECK DEPRESSION INVENTORY-II SCALE (BDI-II). BLOOD SAMPLES WERE COLLECTED BEFORE AND AFTER INTERVENTION FOR THE MEASUREMENT OF THE BIOMARKERS THAT CHARACTERIZE NEUROPLASTICITY, INCLUDING MIND-BODY COMMUNICATIVE AND CELLULAR HEALTH BIOMARKERS. RESULTS: THERE WAS A SIGNIFICANT DECREASE [DIFFERENCE BETWEEN MEANS, (95% CI)] IN BDI-II SCORE [-5.83 (-7.27, -4.39), P < 0.001] AND SIGNIFICANT INCREASE IN BDNF (NG/ML) [5.48 (3.50, 7.46), P < 0.001] AFTER YMLI COMPARED TO CONTROL GROUP. YMLI SIGNIFICANTLY INCREASED DHEAS, SIRTUIN 1, AND TELOMERASE ACTIVITY LEVELS, AND DECREASED CORTISOL, AND IL-6 LEVELS, IN ADDITION TO DECREASING DNA DAMAGE AND BALANCING OXIDATIVE STRESS. MULTIPLE REGRESSION ANALYSES WERE USED TO ASSOCIATE NEUROPLASTICITY BIOMARKERS WITH DEPRESSION SEVERITY. A 'POST-INTERVENTION CHANGE IN BDNF' X 'GROUP' INTERACTION INDICATED THAT YOGA GROUP HAD MORE BDNF IN ASSOCIATION WITH LESS BDI-II SCORES RELATIVE TO CONTROLS. INCREASED SIRTUIN 1 AND TELOMERASE ACTIVITY AND DECREASED CORTISOL SIGNIFICANTLY PREDICTED THIS ASSOCIATION (ALL P < 0.05). CONCLUSION: THESE RESULTS SUGGEST THAT DECREASE IN DEPRESSION SEVERITY AFTER YMLI IN MDD IS ASSOCIATED WITH IMPROVED SYSTEMIC BIOMARKERS OF NEUROPLASTICITY. THUS YMLI CAN BE CONSIDERED AS A THERAPEUTIC INTERVENTION IN MDD MANAGEMENT.	2018	
                                                                                                                                                                                                                                                                                                                                                                                                                
5  527  31 COMPARISON OF LYMPHOCYTE APOPTOTIC INDEX AND QUALITATIVE DNA DAMAGE IN YOGA PRACTITIONERS AND BREAST CANCER PATIENTS: A PILOT STUDY. BACKGROUND: YOGA IS FOUND TO BE EFFECTIVE IN REDUCING STRESS LEVELS AND RADIATION-INDUCED DNA DAMAGE, AND IMPROVING THE QUALITY OF LIFE, IN BREAST CANCER PATIENTS. THE PRESENT STUDY WAS AIMED AT COMPARING THE APOPTOTIC INDEX (AI) AND DNA DAMAGE OF ADVANCED YOGA PRACTITIONERS WITH THOSE OF BREAST CANCER PATIENTS. MATERIALS AND METHODS: THIS CROSS-SECTIONAL PILOT STUDY COMPARED THREE GROUPS (N = 9 EACH) OF AGE-MATCHED SUBJECTS VIZ. (1) CARCINOMA BREAST PATIENTS IN STAGE II OR III UNDERGOING RADIATION THERAPY AFTER COMPLETING THREE CYCLES OF CHEMOTHERAPY; (2) SENIOR YOGA PRACTITIONERS WHO WERE PRACTICING ASANAS, PRANAYAMA AND MEDITATION DAILY FOR MORE THAN 10 YEARS; AND (3) NORMAL HEALTHY VOLUNTEERS. PERIPHERAL BLOOD LYMPHOCYTES WERE ISOLATED, AND QUALITATIVE DNA DAMAGE (QDD) AND AI WERE EVALUATED BY SINGLE-CELL GEL ELECTROPHORESIS ASSAY. APPROXIMATELY 500 CELLS WERE COUNTED IN EACH CASE. NUMBER OF CELLS THAT WERE NORMAL, UNDERGOING APOPTOSIS, AND WITH DNA DAMAGE WERE CATEGORIZED AND PERCENTAGES WERE CALCULATED. RESULTS: DATA BEING NORMALLY DISTRIBUTED, ONE-WAY ANALYSIS OF VARIANCE (ANOVA) SHOWED SIGNIFICANT INTERACTION BETWEEN GROUPS IN AI (P = 0.016) AND QDD (P = 0.045). ON POST-HOC ANALYSIS USING SCHEFFE TEST, AI WAS SIGNIFICANTLY LOWER IN NON-YOGA VOLUNTEERS AS COMPARED WITH THE BREAST CANCER GROUP (P = 0.019) AND QDD WAS SIGNIFICANTLY LOWER IN YOGA PRACTITIONERS WHEN COMPARED WITH NON-YOGA VOLUNTEERS (P = 0.047). CONCLUSION: CELLULAR DYSFUNCTION (QDD) REQUIRES RESTORATIVE MECHANISMS (AI) TO RESTORE THE SYSTEM TO A BALANCE. THE RESULTS OF THIS PILOT STUDY SHOW TRENDS, WHICH INDICATE THAT IN ILL-HEALTH, THERE IS INADEQUATE RESTORATIVE MECHANISMS (AI) ALTHOUGH DYSFUNCTION (QDD) IS HIGH. THROUGH REGULAR PRACTICE OF YOGA, CELLULAR DYSFUNCTION CAN BE LOWERED, THUS NECESSITATING REDUCED RESTORATIVE MECHANISMS. AI AND QDD COULD ALSO BE USEFUL INDICATORS FOR PREDICTING THE THREE ZONES OF HEALTH VIZ. DISEASE, HEALTH, AND POSITIVE HEALTH.	2013	
                                                                                                                                                                                                                                                                                                                                                                                                                                      
6  972  25 EFFECTS OF AN INTEGRATED YOGA PROGRAM IN MODULATING PSYCHOLOGICAL STRESS AND RADIATION-INDUCED GENOTOXIC STRESS IN BREAST CANCER PATIENTS UNDERGOING RADIOTHERAPY. EFFECTS OF AN INTEGRATED YOGA PROGRAM IN MODULATING PERCEIVED STRESS LEVELS, ANXIETY, AS WELL AS DEPRESSION LEVELS AND RADIATION-INDUCED DNA DAMAGE WERE STUDIED IN 68 BREAST CANCER PATIENTS UNDERGOING RADIOTHERAPY. TWO PSYCHOLOGICAL QUESTIONNAIRES--HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS) AND PERCEIVED STRESS SCALE (PSS)--AND DNA DAMAGE ASSAY WERE USED IN THE STUDY. THERE WAS A SIGNIFICANT DECREASE IN THE HADS SCORES IN THE YOGA INTERVENTION GROUP, WHEREAS THE CONTROL GROUP DISPLAYED AN INCREASE IN THESE SCORES. MEAN PSS WAS DECREASED IN THE YOGA GROUP, WHEREAS THE CONTROL GROUP DID NOT SHOW ANY CHANGE PRE- AND POSTRADIOTHERAPY. RADIATION-INDUCED DNA DAMAGE WAS SIGNIFICANTLY ELEVATED IN BOTH THE YOGA AND CONTROL GROUPS AFTER RADIOTHERAPY, BUT THE POSTRADIOTHERAPY DNA DAMAGE IN THE YOGA GROUP WAS SLIGHTLY LESS WHEN COMPARED TO THE CONTROL GROUP. AN INTEGRATED APPROACH OF YOGA INTERVENTION MODULATES THE STRESS AND DNA DAMAGE LEVELS IN BREAST CANCER PATIENTS DURING RADIOTHERAPY.	2007	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
7 1967  26 SERUM CORTISOL AND BDNF IN PATIENTS WITH MAJOR DEPRESSION-EFFECT OF YOGA. DEPRESSION IS ASSOCIATED WITH LOW SERUM BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) AND ELEVATED LEVELS OF SERUM CORTISOL. YOGA PRACTICES HAVE BEEN ASSOCIATED WITH ANTIDEPRESSANT EFFECTS, INCREASE IN SERUM BDNF, AND REDUCTION IN SERUM CORTISOL. THIS STUDY EXAMINED THE ASSOCIATION BETWEEN SERUM BDNF AND CORTISOL LEVELS IN DRUG-NAIVE PATIENTS WITH DEPRESSION TREATED WITH ANTIDEPRESSANTS, YOGA THERAPY, AND BOTH. FIFTY-FOUR DRUG-NAIVE CONSENTING ADULT OUTPATIENTS WITH MAJOR DEPRESSION (32 MALES) RECEIVED ANTIDEPRESSANTS ONLY (N = 16), YOGA THERAPY ONLY (N = 19), OR YOGA WITH ANTIDEPRESSANTS (N = 19). SERUM BDNF ANDCORTISOL LEVELS WERE OBTAINED BEFORE AND AFTER 3 MONTHS USING A SANDWICH ELISA METHOD. ONE-WAY ANOVA, CHI-SQUARE TEST, AND PEARSON'S CORRELATION TESTS WERE USED FOR ANALYSIS. THE GROUPS WERE COMPARABLE AT BASELINE ON MOST PARAMETERS. SIGNIFICANT IMPROVEMENT IN DEPRESSION SCORES AND SERUM BDNF LEVELS, AND REDUCTION IN SERUM CORTISOL IN THE YOGA GROUPS, HAVE BEEN DESCRIBED IN PREVIOUS REPORTS. A SIGNIFICANT NEGATIVE CORRELATION WAS OBSERVED BETWEEN CHANGE IN BDNF (PRE-POST) AND CORTISOL (PRE-POST) LEVELS IN THE YOGA-ONLY GROUP (R = -0.59, P = 0.008). IN CONCLUSION, YOGA MAY FACILITATE NEUROPLASTICITY THROUGH STRESS REDUCTION IN DEPRESSED PATIENTS. FURTHER STUDIES ARE NEEDED TO CONFIRM THE FINDINGS AND DELINEATE THE PATHWAYS FOR THESE EFFECTS.	2016	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
8 2290  28 THERAPEUTIC EFFECT OF YOGA IN PATIENTS WITH HYPERTENSION WITH REFERENCE TO GST GENE POLYMORPHISM. BACKGROUND: HYPERTENSION, A CHRONIC MEDICAL CONDITION OF INCREASED BLOOD PRESSURE, IS A SERIOUS PUBLIC HEALTH PROBLEM. ENVIRONMENTAL AND GENETIC RISK FACTORS ARE KNOWN TO PREDISPOSE TO HYPERTENSION. THE PRESENT STUDY WAS DESIGNED TO INVESTIGATE THE ASSOCIATION OF GLUTATHIONE S-TRANSFERASE (GST) GENE POLYMORPHISM WITH OXIDATIVE STRESS IN HYPERTENSIVE PATIENTS AND THE POSSIBLE BENEFICIAL EFFECT OF YOGA ON THEM. MATERIALS AND METHODS: SIXTY (60) HYPERTENSIVE INDIVIDUALS, BETWEEN 30 AND 60 YEARS OF AGE, WERE DIVIDED INTO TWO GROUPS OF 30 EACH. THE YOGA GROUP WAS SUBJECTED TO 50-60 MINUTES OF YOGIC PRACTICES DAILY FOR 42 DAYS, WHILE THE CONTROL GROUP INCLUDED THE REMAINING 30 AGE- AND SEX-MATCHED HYPERTENSIVE INDIVIDUALS. GST GENE POLYMORPHISM WAS ANALYZED USING MULTIPLE ALLELE SPECIFIC POLYMERASE CHAIN REACTION, AND OXIDATIVE STRESS PARAMETERS WERE ASSESSED BIOCHEMICALLY. RESULTS: ASSESSMENT OF BLOOD PRESSURE SHOWED A STATISTICALLY SIGNIFICANT THOUGH MODEST REDUCTION (P<0.05) IN THE YOGA GROUP AS COMPARED TO THE CONTROL GROUP. MALONDIALDEHYDE WAS OBSERVED TO BE SIGNIFICANTLY LOW (P<0.05), WHILE ANTIOXIDANT CAPACITY IN THE FORM OF GST SHOWED AN INCREASING TREND AND FERRIC-REDUCING ABILITY OF PLASMA WAS SIGNIFICANTLY INCREASED (P<0.05) IN THE SUBJECTS WHO PRACTICED YOGA. CONCLUSIONS: IN CONCLUSION, YOGA HAS BEEN FOUND TO DECREASE BLOOD PRESSURE AS WELL AS THE LEVELS OF OXIDATIVE STRESS IN PATIENTS WITH HYPERTENSION.	2013	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
9 1889  33 REGULAR YOGA PRACTICE IMPROVES ANTIOXIDANT STATUS, IMMUNE FUNCTION, AND STRESS HORMONE RELEASES IN YOUNG HEALTHY PEOPLE: A RANDOMIZED, DOUBLE-BLIND, CONTROLLED PILOT STUDY. OBJECTIVE: THE AIM OF THE PRESENT STUDY IS TO HIGHLIGHT THE BENEFICIAL EFFECTS OF YOGA PRACTICE ON BIO-PARAMETERS, SUCH AS OXIDATIVE STRESS, ANTIOXIDANT COMPONENTS, IMMUNE FUNCTIONS, AND SECRETION OF STRESS HORMONES, IN HEALTHY YOUNG PEOPLE. STUDY DESIGN: THIS STUDY WAS CONDUCTED ON HEALTHY VOLUNTEERS RECRUITED FROM AMONG UNIVERSITY STUDENTS, WHO WERE DIVIDED INTO TWO GROUPS: A CONTROL (NO YOGA INTERVENTION, N=13) GROUP AND A YOGA (N=12) GROUP. YOGA PRACTICE WAS WITH AN INSTRUCTOR FOR 90 MINUTES ONCE A WEEK SPREAD OVER 12 WEEKS, WITH RECOMMENDATIONS TO PRACTICE DAILY AT HOME FOR 40 MINUTES WITH THE HELP OF A DVD. THE YOGA PROGRAM CONSISTED OF YOGA BODY POSES (ASANAS), EXERCISES INVOLVING AWARENESS, VOLUNTARY REGULATION OF BREATH (PRANAYAMA), AND MEDITATIONAL PRACTICES. WHOLE BLOOD SAMPLES WERE COLLECTED WHEN THE VOLUNTEERS HAD FASTED FOR 8 HOURS AT 0 AND 12 WEEKS. THE OXIDATIVE STRESS/ANTIOXIDANT COMPONENTS, IMMUNE-RELATED CYTOKINES, AND STRESS HORMONES WERE EVALUATED IN SERUM OR PLASMA. RESULTS: SERUM LEVELS OF NITRIC OXIDE, F2-ISOPROSTANE, AND LIPID PEROXIDE WERE SIGNIFICANTLY DECREASED BY YOGA PRACTICE (P<0.05 OR P=0.01), WHEREAS SERUM TOTAL GLUTATHIONE (GSH) CONTENTS, ACTIVITIES OF GSH-PEROXIDASE, AND GSH-S-TRANSFERASE WERE REMARKABLY INCREASED AFTER YOGA PRACTICE COMPARED WITH THE CONTROL GROUP (P<0.05 OR P=0.01). YOGA PRACTICE ALSO SIGNIFICANTLY INCREASED IMMUNE-RELATED CYTOKINES, SUCH AS INTERLEUKIN-12, AND INTERFERON-GAMMA, IN SERUM (P<0.05 OR P=0.01). YOGA PRACTICE SIGNIFICANTLY REDUCED THE PLASMA LEVELS OF ADRENALIN (P<0.05) AND INCREASED PLASMA LEVELS OF SEROTONIN COMPARED WITH THE CONTROL GROUP (P<0.05). CONCLUSIONS: REGULAR YOGA PRACTICE REMARKABLY ATTENUATED OXIDATIVE STRESS AND IMPROVED ANTIOXIDANT LEVELS OF THE BODY. MOREOVER, YOGA BENEFICIALLY AFFECTED STRESS HORMONE RELEASES AS WELL AS PARTIALLY IMPROVED IMMUNE FUNCTION.	2015	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
10  284  27 ADIPONECTIN, INTERLEUKIN-6, AND CARDIOVASCULAR DISEASE RISK FACTORS ARE MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT AND OBESE MEN. OBJECTIVE: TO INVESTIGATE THE EFFECT OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION ON RISK FACTORS FOR CARDIOVASCULAR DISEASE (CVD) AND MARKERS OF INFLAMMATION AND ENDOTHELIAL FUNCTION IN OVERWEIGHT AND OBESE MEN. DESIGN: NONRANDOMIZED PROSPECTIVE LIFESTYLE INTERVENTION STUDY WITH PRE-POST DESIGN. SETTING AND LOCATION: INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY PROVIDING YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. SUBJECTS: OVERWEIGHT AND OBESE MEN (N=51) WERE ENROLLED IN THE STUDY. SUBJECTS WHO WERE PHYSICALLY UNABLE TO PARTICIPATE AND THOSE PARTICIPATING IN OTHER INTERVENTIONS WERE EXCLUDED FROM THE STUDY. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDING ASANAS (PHYSICAL POSTURES), PRANAYAMA (BREATHING EXERCISES), GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. OUTCOME MEASURES: THE PRIMARY OUTCOME MEASURE WAS WEIGHT LOSS, AND THE SECONDARY OUTCOME MEASURES WERE CLINICAL AND LABORATORY CORRELATES OF CVD RISK, LEVELS OF INTERLEUKIN-6 (IL-6), ADIPONECTIN, AND ENDOTHELIN-1 (ET-1). RESULTS: MEN (N=51, BODY MASS INDEX [BMI] 26.26+/-2.42 KG/M(2)) WERE ENROLLED AND UNDERWENT A YOGA-BASED LIFESTYLE INTERVENTION FOR 10 DAYS. OF 51 SUBJECTS, 30 COMPLETED THE STUDY. THERE WAS A SIGNIFICANT REDUCTION IN WEIGHT FROM BASELINE TO DAY 10 (74.60+/-7.98, 72.69+/-8.37 KG, P<0.001, RESPECTIVELY), BMI (26.26+/-2.42, 25.69+/-2.47 KG/M(2), P<0.001, RESPECTIVELY), AND SYSTOLIC BP (121.73+/-11.58, 116.73+/-9.00, P=0.042, RESPECTIVELY). THERE WAS A SIGNIFICANT REDUCTION IN PLASMA IL-6 FROM BASELINE TO DAY 10 (MEDIAN 2.24 VS. 1.26 PG/ML, RESPECTIVELY, P=0.012). THERE WAS A SIGNIFICANT INCREASE IN THE PLASMA ADIPONECTIN FROM BASELINE TO DAY 10 (MEDIAN 4.95 VS. 6.26 MUG/ML, RESPECTIVELY, P=0.014). PLASMA ET-1 LEVEL REMAINED UNCHANGED. CONCLUSION: THESE FINDINGS SUGGEST THAT EVEN A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION MAY BE AN IMPORTANT MODALITY TO REDUCE THE RISK FOR CVD AS INDICATED BY WEIGHT LOSS, REDUCTION IN SYSTOLIC BLOOD PRESSURE, AN INCREASE IN ADIPONECTIN, AND DECREASE IN IL-6 IN OVERWEIGHT AND OBESE MEN.	2013	
                                                                                                                                                                                                                                                             
11  716  31 EFFECT OF INTEGRATED YOGA PRACTICES ON IMMUNE RESPONSES IN EXAMINATION STRESS - A PRELIMINARY STUDY. BACKGROUND: STRESS IS OFTEN ASSOCIATED WITH AN INCREASED OCCURRENCE OF AUTONOMIC, CARDIOVASCULAR, AND IMMUNE SYSTEM PATHOLOGY. THIS STUDY WAS DONE TO EVALUATE THE IMPACT OF STRESS ON PSYCHOLOGICAL, PHYSIOLOGICAL PARAMETERS, AND IMMUNE SYSTEM DURING MEDICAL TERM -ACADEMIC EXAMINATION AND THE EFFECT OF YOGA PRACTICES ON THE SAME. MATERIALS AND METHODS: THE STUDY WAS CARRIED OUT ON SIXTY FIRST-YEAR MBBS STUDENTS RANDOMLY ASSIGNED TO YOGA GROUP AND CONTROL GROUP (30 EACH). THE YOGA GROUP UNDERWENT INTEGRATED YOGA PRACTICES FOR 35 MINUTES DAILY IN THE PRESENCE OF TRAINED YOGA TEACHER FOR 12 WEEKS. CONTROL GROUP DID NOT UNDERGO ANY KIND OF YOGA PRACTICE OR STRESS MANAGEMENT. PHYSIOLOGICAL PARAMETERS LIKE HEART RATE, RESPIRATORY RATE, AND BLOOD PRESSURE WERE MEASURED. GLOBAL ASSESSMENT OF RECENT STRESS SCALE AND SPIELBERGERS STATE ANXIETY SCORE WERE ASSESSED AT BASELINE AND DURING THE EXAMINATION. SERUM CORTISOL LEVELS, IL-4, AND IFN-GAMMA LEVELS WERE DETERMINED BY ENZYME-LINKED IMMUNOSORBENT ASSAY TECHNIQUE. RESULT: IN THE YOGA GROUP, NO SIGNIFICANT DIFFERENCE WAS OBSERVED IN PHYSIOLOGICAL PARAMETERS DURING THE EXAMINATION STRESS, WHEREAS IN THE CONTROL GROUP, A SIGNIFICANT INCREASE WAS OBSERVED. LIKEWISE, THE INDICATORS OF PSYCHOLOGICAL STRESS SHOWED HIGHLY SIGNIFICANT DIFFERENCE IN CONTROL GROUP COMPARED WITH SIGNIFICANT DIFFERENCE IN YOGA GROUP. DURING THE EXAMINATION, THE INCREASE IN SERUM CORTICAL AND DECREASE IN SERUM IFN-GAMMA IN YOGA GROUP WAS LESS SIGNIFICANT (P<0.01) THAN IN THE CONTROL GROUP (P<0.001). BOTH THE GROUPS DEMONSTRATED AN INCREASE IN SERUM IL-4 LEVELS, THE CHANGES BEING INSIGNIFICANT FOR THE DURATION OF THE STUDY. CONCLUSION: YOGA RESISTS THE AUTONOMIC CHANGES AND IMPAIRMENT OF CELLULAR IMMUNITY SEEN IN EXAMINATION STRESS.	2011	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
12 1491  29 INTERLEUKIN-6, VITAMIN D & DIABETES RISK-FACTORS MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT/OBESE INDIVIDUALS. BACKGROUND & OBJECTIVES: SEVERAL DIABETES PREVENTION PROGRAMMES HAVE DEMONSTRATED A REDUCTION IN INCIDENCE OF DIABETES IN INDIVIDUALS WITH PREDIABETES THROUGH WEIGHT LOSS. SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION PROGRAMMES HAVE ALSO BEEN SHOWN TO BE EFFICACIOUS IN WEIGHT LOSS. THIS STUDY WAS UNDERTAKEN TO INVESTIGATE IF INTERLEUKIN (IL)-6, VITAMIN D, NEOPTERIN, VASPIN, AND DIABETES RISK FACTORS CAN BE MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OVERWEIGHT/OBESE SUBJECTS. METHODS: IN THIS PILOT STUDY, 34 OVERWEIGHT/OBESE [BODY MASS INDEX (BMI) >/= 23 TO <35 KG/M [2] PER ASIAN CUT-OFF VALUES] INDIVIDUALS WERE ENROLLED, AND RECEIVED DIRECTLY SUPERVISED INTERVENTION FOR 10 DAYS. THEREAFTER, THEY WERE ADVISED TO FOLLOW THIS YOGA-BASED LIFESTYLE AT HOME FOR ONE MONTH, AND WERE REASSESSED FOR STUDY VARIABLES AT DAY 30. RESULTS: THERE WAS A REDUCTION FROM BASELINE TO DAY 10 IN WEIGHT ( P <0.001), BMI ( P <0.001), WAIST/HIP-RATIO ( P <0.05), BLOOD GLUCOSE ( P <0.01), AND A SIGNIFICANT IMPROVEMENT IN LIPID PROFILE. THERE WAS A DECREASE IN MEDIAN FASTING INSULIN ( P <0.05), HOMEOSTATIC MODEL ASSESSMENT-INSULIN RESISTANCE ( P <0.01), AND IL-6 ( PP <0.05). A NON-SIGNIFICANT INCREASE IN 25-OH-VITAMIN D, AND A DECREASE IN NEOPTERIN AND VASPIN WERE OBSERVED. TWENTY SUBJECTS RETURNED FOR FOLLOW UP ASSESSMENTS. AT DAY 30, WEIGHT LOSS WAS SUSTAINED WHILE SYSTOLIC BLOOD PRESSURE ALSO SHOWED REDUCTION ( P <0.05). CHANGES IN VITAMIN D LEVELS WERE SIGNIFICANTLY AND NEGATIVELY CORRELATED WITH CHANGES IN WEIGHT, BMI AND FASTING BLOOD GLUCOSE, AND POSITIVELY WITH CHANGE IN HIGH DENSITY LIPOPROTEIN. CHANGES IN BODY WEIGHT AND BMI SIGNIFICANTLY AND POSITIVELY CORRELATED WITH INSULIN. CHANGES IN IL-6 LEVELS POSITIVELY AND SIGNIFICANTLY CORRELATED WITH CHANGE IN NEOPTERIN LEVELS. INTERPRETATION & CONCLUSIONS: THE FINDINGS SHOWED THAT IL-6, VITAMIN D, AND DIABETES RISK FACTORS WERE FAVOURABLY MODIFIED BY A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN OBESITY. THIS STUDY ALSO HIGHLIGHTED THE CHALLENGES IN COMPLIANCE ASSOCIATED WITH THE FOLLOW UP OF SUBJECTS FOLLOWING AN AGGRESSIVE SUPERVISED INTERVENTION OF 10 DAYS.	2015	
                                                                                                                                                                                                                                     
13 1426  33 IMPROVEMENT OF GLUTATHIONE AND TOTAL ANTIOXIDANT STATUS WITH YOGA. OBJECTIVE: SEVERAL STUDIES SUGGEST THAT YOGA CAN DECREASE OXIDATIVE STRESS. HOWEVER REPORTS ARE SCANTY REGARDING WHETHER YOGA TRAINING CAN IMPROVE THE GLUTATHIONE LEVEL OF INDIVIDUAL. THIS STUDY IS DESIGNED TO APPRAISE THE ROLE OF YOGA IN MAINTAINING GLUTATHIONE (REDUCED AND OXIDIZED) LEVELS AND ANTIOXIDANT STATUS. STUDY DESIGN: THIS STUDY WAS CONDUCTED ON HEALTHY MALE VOLUNTEERS FROM THE INDIAN NAVY, WHO WERE DIVIDED INTO TWO GROUPS--A YOGA (N = 30) GROUP AND A CONTROL (N = 21) GROUP. THE YOGA GROUP WAS TRAINED IN YOGA FOR 6 MONTHS. THE YOGA SCHEDULE CONSISTED OF PRAYERS, ASANA, PRANAYAMA, AND MEDITATION. THE CONTROL GROUP PRACTICED ROUTINE PHYSICAL TRAINING EXERCISE FOR 6 MONTHS. BLOOD SAMPLES WERE COLLECTED WHEN THE VOLUNTEERS WERE IN FASTING CONDITION BEFORE AND AFTER COMPLETION OF 6-MONTH TRAINING PERIOD. REDUCED AND OXIDIZED GLUTATHIONE, GLUTATHIONE REDUCTASE ACTIVITY AND TOTAL ANTIOXIDANT STATUS (TAS) WERE ESTIMATED. RESULTS: REDUCED GLUTATHIONE LEVEL INCREASED SIGNIFICANTLY (P < 0.05) IN THE YOGA GROUP AFTER COMPLETION OF TRAINING. GLUTATHIONE REDUCTASE ACTIVITY INCREASED SIGNIFICANTLY IN THE CONTROL GROUP (P < 0.05). TAS INCREASED SIGNIFICANTLY (P < 0.001) IN THE YOGA GROUP AND DECREASED SIGNIFICANTLY (P < 0.001) IN THE CONTROL GROUP. CONCLUSIONS: REGULAR PRACTICE OF YOGA CAN MAINTAIN OR IMPROVE ANTIOXIDANT LEVEL OF THE BODY. THE CLINICAL RELEVANCE IS THAT YOGA PRACTICE CAN BE USED TO MAINTAIN THE ANTIOXIDANT DEFENSE SYSTEM UNDER STRESSFUL CONDITIONS OF TRAINING AS OBSERVED IN THE CASE OF SOLDIERS AND ATHLETES.	2007	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
14 1115  31 EFFICACY OF A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION IN REDUCING STRESS AND INFLAMMATION: PRELIMINARY RESULTS. OBJECTIVES: PREVIOUSLY IT WAS SHOWN THAT A BRIEF YOGA-BASED LIFESTYLE INTERVENTION WAS EFFICACIOUS IN REDUCING OXIDATIVE STRESS AND RISK OF CHRONIC DISEASES EVEN IN A SHORT DURATION. THE OBJECTIVE OF THIS STUDY WAS TO ASSESS THE EFFICACY OF THIS INTERVENTION IN REDUCING STRESS AND INFLAMMATION IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES. DESIGN: THIS STUDY REPORTS PRELIMINARY RESULTS FROM A NONRANDOMIZED PROSPECTIVE ONGOING STUDY WITH PRE-POST DESIGN. SETTING/LOCATION: THE STUDY WAS CONDUCTED AT THE INTEGRAL HEALTH CLINIC, AN OUTPATIENT FACILITY CONDUCTING THESE YOGA-BASED LIFESTYLE INTERVENTION PROGRAMS FOR PREVENTION AND MANAGEMENT OF CHRONIC DISEASES. SUBJECTS: PATIENTS WITH CHRONIC INFLAMMATORY DISEASES AND OVERWEIGHT/OBESE SUBJECTS WERE INCLUDED WHILE PHYSICALLY CHALLENGED, AND THOSE ON OTHER INTERVENTIONS WERE EXCLUDED FROM THE STUDY. INTERVENTION: A PRETESTED INTERVENTION PROGRAM INCLUDED ASANAS (POSTURES), PRANAYAMA (BREATHING EXERCISES), STRESS MANAGEMENT, GROUP DISCUSSIONS, LECTURES, AND INDIVIDUALIZED ADVICE. OUTCOME MEASURES: THERE WAS A REDUCTION IN STRESS (PLASMA CORTISOL AND BETA-ENDORPHIN) AND INFLAMMATION (INTERLEUKIN [IL]-6 AND TUMOR NECROSIS FACTOR [TNF]-ALPHA) AT DAY 0 VERSUS DAY 10. RESULTS: EIGHTY-SIX (86) PATIENTS (44 FEMALE, 42 MALE, 40.07 +/- 13.91 YEARS) ATTENDED THIS PROGRAM. OVERALL, THE MEAN LEVEL OF CORTISOL DECREASED FROM BASELINE TO DAY 10 (149.95 +/- 46.07, 129.07 +/- 33.30 NG/ML; P=0.001) WHILE BETA-ENDORPHINS INCREASED FROM BASELINE TO DAY 10 (3.53 +/- 0.88, 4.06 +/- 0.79 NG/ML; P=0.024). ALSO, THERE WAS REDUCTION FROM BASELINE TO DAY 10 IN MEAN LEVELS OF IL-6 (2.16 +/- 0.42, 1.94 +/- 0.10 PG/ML, P=0.036) AND TNF-ALPHA (2.85 +/- 0.59, 1.95 +/- 0.32 PG/ML, P=0.002). CONCLUSIONS: THIS BRIEF YOGA-BASED LIFESTYLE INTERVENTION REDUCED THE MARKERS OF STRESS AND INFLAMMATION AS EARLY AS 10 DAYS IN PATIENTS WITH CHRONIC DISEASES; HOWEVER, COMPLETE RESULTS OF THIS STUDY WILL CONFIRM WHETHER THIS PROGRAM HAS UTILITY AS COMPLEMENTARY AND ALTERNATIVE THERAPY.	2012	
                                                                                                                                                                                                                                                                                                                                                                                             
15  835  26 EFFECT OF YOGA ON PAIN, BRAIN-DERIVED NEUROTROPHIC FACTOR, AND SEROTONIN IN PREMENOPAUSAL WOMEN WITH CHRONIC LOW BACK PAIN. BACKGROUND. SEROTONIN AND BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) ARE KNOWN TO BE MODULATORS OF NOCICEPTION. HOWEVER, PAIN-RELATED CONNECTION BETWEEN YOGA AND THOSE NEUROMODULATORS HAS NOT BEEN INVESTIGATED. THEREFORE, WE AIMED TO EVALUATE THE EFFECT OF YOGA ON PAIN, BDNF, AND SEROTONIN. METHODS. PREMENOPAUSAL WOMEN WITH CHRONIC LOW BACK PAIN PRACTICED YOGA THREE TIMES A WEEK FOR 12 WEEKS. AT BASELINE AND AFTER 12 WEEKS, BACK PAIN INTENSITY WAS MEASURED USING VISUAL ANALOGUE SCALE (VAS), AND SERUM BDNF AND SEROTONIN LEVELS WERE EVALUATED. ADDITIONALLY, BACK FLEXIBILITY AND LEVEL OF DEPRESSION WERE ASSESSED. RESULTS. AFTER 12-WEEK YOGA, VAS DECREASED IN THE YOGA GROUP (P < 0.001), WHEREAS IT INCREASED (P < 0.05) IN THE CONTROL GROUP. BACK FLEXIBILITY WAS IMPROVED IN THE YOGA GROUP (P < 0.01). SERUM BDNF INCREASED IN THE YOGA GROUP (P < 0.01), WHEREAS IT TENDED TO DECREASE IN THE CONTROL GROUP (P = 0.05). SERUM SEROTONIN MAINTAINED IN THE YOGA GROUP, WHILE IT REDUCED (P < 0.01) IN THE CONTROL GROUP. THE DEPRESSION LEVEL MAINTAINED IN THE YOGA GROUP, WHEREAS IT TENDED TO INCREASE IN THE CONTROL GROUP (P = 0.07). CONCLUSIONS. WE PROPOSE THAT BDNF MAY BE ONE OF THE KEY FACTORS MEDIATING BENEFICIAL EFFECTS OF YOGA ON CHRONIC LOW BACK PAIN.	2014	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
16  515  26 COMPARING BETWEEN THE EFFECT OF ENERGY-RESTRICTED DIET AND YOGA ON THE RESTING METABOLIC RATE, ANTHROPOMETRIC INDICES, AND SERUM ADIPOKINE LEVELS IN OVERWEIGHT AND OBESE STAFF WOMEN. BACKGROUND: WEIGHT MANAGEMENT IS AN IMPORTANT STRATEGY TO PREVENT THE CONSEQUENCES OF OBESITY. THE AIM OF THE STUDY WAS TO COMPARE THE EFFECT OF YOGA PRACTICE AND ENERGY-RESTRICTED DIET ON RESTING METABOLIC RATE (RMR), ANTHROPOMETRIC INDICES, AND SERUM ADIPONECTIN AND LEPTIN IN OVERWEIGHT AND OBESE WOMEN. MATERIALS AND METHODS: OBESE OR OVERWEIGHT WOMEN WERE DIVIDED INTO TWO GROUPS: YOGA PRACTICING AND ENERGY-RESTRICTED DIET. EXERCISE TRIALS CONSISTED OF 60-MIN HATHA YOGA EQUAL TO 200 KILOCALORIES (KCAL) COMBINED WITH 300 KCAL RESTRICTION PER DAY, AND AN ENERGY-RESTRICTED DIET CONSISTED OF 500 KCAL RESTRICTION PER DAY. THE INTERVENTION PERIOD FOR BOTH THE GROUPS WAS 8 WEEKS. RMR, ANTHROPOMETRIC INDICES, AND SERUM ADIPONECTIN, LEPTIN, AND LIPID PROFILES WERE MEASURED AT BASELINE AND AT THE END OF THE STUDY. RESULTS: RMR WAS INCREASED IN YOGA BUT NOT IN THE DIET GROUP (P = 0.001). THE LEVEL OF ADIPONECTIN WAS INCREASED IN THE YOGA GROUP COMPARED WITH THE DIET (P = 0.035). THE CONCENTRATION OF HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL WAS DECREASED IN THE DIET GROUP SIGNIFICANTLY BUT NOT IN YOGA (P = 0.006). THE LEVEL OF LEPTIN WAS DECREASED IN BOTH THE GROUPS (P = 0.001), AND THERE WERE NO SIGNIFICANT DIFFERENCES BETWEEN THE TWO GROUPS. CONCLUSION: THE FINDINGS OF THE STUDY DEMONSTRATED THE EFFECT OF YOGA PRACTICING ON RMR, AND SERUM ADIPONECTIN, IN OVERWEIGHT AND OBESE WOMEN. IT SEEMS YOGA PRACTICE WITH LESS ENERGY RESTRICTION COMPARED WITH A COMMON ENERGY RESTRICTION DIET AND IS MORE EFFECTIVE IN WEIGHT MANAGEMENT FOR THOSE WHO ARE IN WEIGHT LOSS PROGRAMS.	2020	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
17  796  29 EFFECT OF YOGA INTERVENTION ON BIOCHEMICAL, OXIDATIVE STRESS MARKERS, INFLAMMATORY MARKERS AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES IN SOUTH INDIA: RESULTS FROM THE SATYAM PROJECT. AIMS: THE AIM OF THIS STUDY WAS TO INVESTIGATE THE EFFECT OF YOGA INTERVENTION ON THE BIOCHEMICAL, OXIDATIVE STRESS MARKERS AND INFLAMMATORY MARKERS AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES. METHODS: SUBJECTS WITH TYPE 2 DIABETES ATTENDING A TERTIARY CARE CENTRE FOR DIABETES DURING FEB 2017 TO OCT 2019 IN CHENNAI, INDIA WERE RANDOMLY ASSIGNED TO TWO DIFFERENT GROUPS. GROUP1(NON-YOGA) (N = 150) WAS ADVISED ON SIMPLE PHYSICAL EXERCISES WHEREAS GROUP2(YOGA) (N = 150) WAS TRAINED AND ADVISED TO DO YOGASANAS WITH STATIC LOOSENING EXERCISES FOR 50 MIN FOR 5 DAYS IN A WEEK. BOTH THE GROUPS WERE FOLLOWED UP FOR A PERIOD OF 3 MONTHS. ANTHROPOMETRIC, BIOCHEMICAL, OXIDATIVE STRESS MARKERS, INFLAMMATORY MARKERS AND SLEEP QUALITY WERE ASSESSED AT BASELINE AND AFTER FOLLOW UP. RESULTS: THERE WAS A SIGNIFICANT REDUCTION IN BMI, BLOOD GLUCOSE LEVELS, HBA1C, LIPID LEVELS, IL6, TNFALPHA AND TBARS IN YOGA GROUP AS COMPARED TO NON-YOGA GROUP. THERE WAS MARKED IMPROVEMENT IN THE LEVELS OF ADIPONECTIN, PTGIS AND SLEEP QUALITY AMONG SUBJECTS PRACTISING YOGASANAS. CONCLUSION: REGULAR PRACTICE OF YOGASANAS IMPROVED GLYCAEMIC CONTROL, OXIDATIVE STRESS, INFLAMMATORY RESPONSE AND SLEEP QUALITY AMONG SUBJECTS WITH TYPE 2 DIABETES. HENCE, YOGASANAS CAN BE USED AS AN ADJUVANT THERAPY FOR MANAGING TYPE 2 DIABETES.	2021	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
18 2768  31 YOGA REDUCES INFLAMMATORY SIGNALING IN FATIGUED BREAST CANCER SURVIVORS: A RANDOMIZED CONTROLLED TRIAL. BACKGROUND: YOGA IS A POPULAR MIND-BODY THERAPY THAT HAS DEMONSTRATED BENEFICIAL EFFECTS ON PSYCHOLOGICAL, BEHAVIORAL, AND FUNCTIONAL OUTCOMES. HOWEVER, FEW STUDIES HAVE INVESTIGATED EFFECTS ON INFLAMMATORY PROCESSES. THIS STUDY TESTED THE HYPOTHESIS THAT AN IYENGAR YOGA INTERVENTION SPECIFICALLY DESIGNED FOR FATIGUED BREAST CANCER SURVIVORS WOULD LEAD TO DECREASES IN INFLAMMATION-RELATED GENE EXPRESSION AND CIRCULATING MARKERS OF PROINFLAMMATORY CYTOKINE ACTIVITY. METHODS: BREAST CANCER SURVIVORS WITH PERSISTENT CANCER-RELATED FATIGUE WERE RANDOMIZED TO A 12-WEEK IYENGAR YOGA INTERVENTION (N=16) OR A 12-WEEK HEALTH EDUCATION CONTROL CONDITION (N=15). BLOOD SAMPLES WERE COLLECTED AT BASELINE, POST-INTERVENTION, AND AT A 3-MONTH FOLLOW-UP FOR GENOME-WIDE TRANSCRIPTIONAL PROFILING AND BIOINFORMATIC ANALYSES. PLASMA INFLAMMATORY MARKERS AND SALIVARY CORTISOL WERE ALSO ASSESSED. RESULTS: IN PROMOTER-BASED BIOINFORMATICS ANALYSES, THE YOGA GROUP SHOWED REDUCED ACTIVITY OF THE PRO-INFLAMMATORY TRANSCRIPTION FACTOR NUCLEAR FACTOR KAPPA B (NF-KAPPAB), INCREASED ACTIVITY OF THE ANTI-INFLAMMATORY GLUCOCORTICOID RECEPTOR, AND REDUCED ACTIVITY OF CAMP RESPONSE ELEMENT-BINDING PROTEIN (CREB) FAMILY TRANSCRIPTION FACTORS RELATIVE TO CONTROLS (ALL PS<.05). THERE WAS ALSO A SIGNIFICANT INTERVENTION EFFECT ON THE SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TYPE II (STNF-RII), A MARKER OF TNF ACTIVITY; PLASMA LEVELS OF STNF-RII REMAINED STABLE IN THE YOGA GROUP, WHEREAS LEVELS OF THIS MARKER INCREASED IN THE HEALTH EDUCATION GROUP (P=.028). A SIMILAR, NON-SIGNIFICANT TREND WAS OBSERVED FOR THE INTERLEUKIN 1 RECEPTOR ANTAGONIST (P=.16). NO SIGNIFICANT CHANGES IN C REACTIVE PROTEIN (CRP), INTERLEUKIN 6 (IL-6), OR DIURNAL CORTISOL MEASURES WERE OBSERVED. CONCLUSIONS: A 12-WEEK RESTORATIVE IYENGAR YOGA INTERVENTION REDUCED INFLAMMATION-RELATED GENE EXPRESSION IN BREAST CANCER SURVIVORS WITH PERSISTENT FATIGUE. THESE FINDINGS SUGGEST THAT A TARGETED YOGA PROGRAM MAY HAVE BENEFICIAL EFFECTS ON INFLAMMATORY ACTIVITY IN THIS PATIENT POPULATION, WITH POTENTIAL RELEVANCE FOR BEHAVIORAL AND PHYSICAL HEALTH.	2014	
                                                                                                                                                                                                                                                                                                               
19  748  25 EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. OBJECTIVE: THE PRESENT STUDY INVESTIGATES THE EFFECT OF SAHAJA YOGA MEDITATION ON QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE CONTROL. DESIGN: THE PROSPECTIVE OBSERVATIONAL COHORT STUDY ENROLLED TWO STUDY GROUPS: THOSE RECEIVING TREATMENT FROM THE INTERNATIONAL SAHAJA YOGA RESEARCH AND HEALTH CENTER (MEDITATION GROUP) AND THOSE RECEIVING TREATMENT FROM THE MAHATMA GANDHI MISSION HOSPITAL (CONTROL GROUP). RESEARCHERS MEASURED QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE BEFORE AND AFTER TREATMENT. RESULTS: SIXTY-SEVEN (67) PARTICIPANTS IN THE MEDITATION GROUP AND 62 PARTICIPANTS IN THE CONTROL GROUP COMPLETED THE STUDY. THE TWO GROUPS WERE COMPARABLE IN DEMOGRAPHIC AND CLINICAL CHARACTERISTICS. AT BASELINE, THE MEDITATION GROUP HAD HIGHER QUALITY OF LIFE (P<0.001) THAN CONTROLS BUT SIMILAR ANXIETY LEVEL (P=0.74) TO CONTROLS. WITHIN-GROUP PRE- VERSUS POST-TREATMENT COMPARISONS SHOWED SIGNIFICANT IMPROVEMENT IN QUALITY OF LIFE, ANXIETY, AND BLOOD PRESSURE IN THE MEDITATION GROUP (P<0.001), WHILE IN CONTROLS, QUALITY OF LIFE DETERIORATED AND THERE WAS NO IMPROVEMENT IN BLOOD PRESSURE. THE IMPROVEMENT IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL WAS GREATER IN THE MEDITATION GROUP. THE BENEFICIAL EFFECT OF MEDITATION REMAINED SIGNIFICANT AFTER ADJUSTING FOR CONFOUNDERS. CONCLUSIONS: MEDITATION TREATMENT WAS ASSOCIATED WITH SIGNIFICANT IMPROVEMENTS IN QUALITY OF LIFE, ANXIETY REDUCTION, AND BLOOD PRESSURE CONTROL.	2012	
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
20  819  29 EFFECT OF YOGA ON DEPRESSION IN HYPOTHYROIDISM: A PILOT STUDY. BACKGROUND: THE PREVALENCE OF HYPOTHYROIDISM AMONG INDIAN WOMEN IS 15.8%. DEPRESSION IS FREQUENTLY REPORTED IN HYPOTHYROIDISM. YOGA IS AN EFFECTIVE INTERVENTION FOR DEPRESSION. HOWEVER, THE INFLUENCE OF YOGA ON DEPRESSION IN PATIENTS WITH HYPOTHYROIDISM HAS NOT BEEN STUDIED. AIM: THE PRESENT STUDY INVESTIGATED THE EFFECT OF A 3-MONTH INTEGRATED YOGA INTERVENTION (3-IY) ON DEPRESSION, LIPID INDICES, AND SERUM THYROID-STIMULATING HORMONE (STSH) LEVELS AMONG FEMALE PATIENTS HAVING HYPOTHYROIDISM, AND MILD-TO-MODERATE DEPRESSION. METHOD: THE PRESENT SINGLE-ARM PRE-POST DESIGN STUDY WAS CONDUCTED IN THIRTY-EIGHT WOMEN (AVERAGE AGE 34.2 +/- 4.7 YEARS). PARTICIPANTS RECEIVED A 3-IY COMPRISING ASANAS, PRANAYAMA, AND RELAXATION TECHNIQUES FOR 60 MIN DAILY (5 DAYS A WEEK). DEPRESSION, STSH, LIPID PROFILE INDICES, BODY MASS INDEX (BMI), FATIGUE, ANXIETY, AND STRESS WERE ASSESSED AT BASELINE AND AFTER 12 WEEKS. THYROID MEDICATION WAS KEPT CONSTANT DURING THE STUDY PERIOD. DATA WERE ANALYSED USING R STUDIO SOFTWARE. RESULT: A SIGNIFICANT (P < 0.05) REDUCTION IN DEPRESSION (58%), STSH (37%), BMI (6%), FATIGUE (64%), ANXIETY (57%), LIPID PROFILE INDICES (HLD INCREASED SIGNIFICANTY), AND STRESS (55%) LEVELS WAS OBSERVED AFTER 3 MONTHS, COMPARED WITH THE CORRESPONDING BASELINE LEVELS. CONCLUSION: THE 3-IY IS USEFUL FOR REDUCING DEPRESSION, DYSLIPIDEMIA, AND STSH IN WOMEN WITH HYPOTHYROIDISM AND DEPRESSION. FURTHER STUDIES WITH A LARGER SAMPLE SIZE AND A ROBUST RESEARCH DESIGN USING OBJECTIVE VARIABLES MUST BE CONDUCTED TO STRENGTHEN THE STUDY FINDINGS.	2021